FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2810396346> ?p ?o ?g. }

• W2810396346 endingPage "981" @default.
• W2810396346 startingPage "981" @default.
• W2810396346 abstract "Despite high rates of local tumor control in patients who are treated for uveal melanoma, most patients will eventually die of metastasis. When metastasis develops, the liver is involved in most cases, and hepatic metastases are particularly refractory to treatment. Finding effective treatments has been challenging. A comparison of survival rates in patients who were treated for metastasis over approximately 30 years may offer insights into progress that has been made in prolonging survival.To compare survival after treatment for metastasis in a cohort of patients who were treated for uveal melanoma at the Massachusetts Eye and Ear Infirmary (MEE) during an approximately 30-year period with an earlier analysis to determine if there was meaningful improvement in survival rates after treatment for metastasis.This review included patients (n = 661) who received a diagnosis of metastasis from uveal melanoma who were identified from a cohort of 3063 patients treated at MEE between January 1982 and December 2009 and followed up through December 2011. They were compared with findings from a previous study of patients treated between 1975 and 1987.Survival rates in patients who received treatment for metastasis were compared with those who did not receive treatment. The differences in survival rates were compared with an earlier analysis that was completed at MEE. A comparison of patients with hepatic metastases and extrahepatic metastases was also completed. Kaplan-Meier analysis was used to calculate survival rates and the log rank test was used to test for statistically significant differences between the groups.Of 620 patients with race information available, 615 (97.3%) were white; the mean (SD) age of patients was 59.71 (13.23) years and 307 (47.3%) were women. The median time from the initial treatment of the tumor to metastasis was 3.45 years (interquartile range [IQR], 2.0-5.57). Overall, the median survival time was poor (3.9 months [IQR, 1.6-10.1]). Patients who received treatment fared better than those who did not receive treatment (median survival after metastasis diagnosis, 6.3 months [IQR, 2.96-14.41] vs 1.7 months [IQR, 0.66-3.5]). This finding was similar to that of our earlier study in which median survival was 5.2 months and 2 months for treated and untreated patients, respectively.These findings suggest that advances in treatments that lead to clinically meaningful improvements in survival times have not been realized. Similar survival rates in patients who were treated for metastasis were observed in this recent analysis compared with our earlier study. Adjuvant therapies that are initiated at the time of melanoma diagnosis may be the most effective way to prolong survival." @default.
• W2810396346 created "2018-07-10" @default.
• W2810396346 creator A5011881123 @default.
• W2810396346 creator A5021784289 @default.
• W2810396346 creator A5053500368 @default.
• W2810396346 date "2018-09-01" @default.
• W2810396346 modified "2023-10-02" @default.
• W2810396346 title "Survival Rates in Patients After Treatment for Metastasis From Uveal Melanoma" @default.
• W2810396346 cites W13404829 @default.
• W2810396346 cites W1508871122 @default.
• W2810396346 cites W1983878962 @default.
• W2810396346 cites W2011556296 @default.
• W2810396346 cites W2014120362 @default.
• W2810396346 cites W2018032989 @default.
• W2810396346 cites W2038434969 @default.
• W2810396346 cites W2055835855 @default.
• W2810396346 cites W2071696483 @default.
• W2810396346 cites W2091174084 @default.
• W2810396346 cites W2109536183 @default.
• W2810396346 cites W2110920908 @default.
• W2810396346 cites W2147850345 @default.
• W2810396346 cites W2160903712 @default.
• W2810396346 cites W2165636771 @default.
• W2810396346 cites W2233380081 @default.
• W2810396346 cites W2320786076 @default.
• W2810396346 cites W2326441340 @default.
• W2810396346 cites W2334064776 @default.
• W2810396346 cites W2342586635 @default.
• W2810396346 cites W2502228174 @default.
• W2810396346 cites W2515516401 @default.
• W2810396346 cites W2516337088 @default.
• W2810396346 doi "https://doi.org/10.1001/jamaophthalmol.2018.2466" @default.
• W2810396346 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6142974" @default.
• W2810396346 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29955797" @default.
• W2810396346 hasPublicationYear "2018" @default.
• W2810396346 type Work @default.
• W2810396346 sameAs 2810396346 @default.
• W2810396346 citedByCount "72" @default.
• W2810396346 countsByYear W28103963462019 @default.
• W2810396346 countsByYear W28103963462020 @default.
• W2810396346 countsByYear W28103963462021 @default.
• W2810396346 countsByYear W28103963462022 @default.
• W2810396346 countsByYear W28103963462023 @default.
• W2810396346 crossrefType "journal-article" @default.
• W2810396346 hasAuthorship W2810396346A5011881123 @default.
• W2810396346 hasAuthorship W2810396346A5021784289 @default.
• W2810396346 hasAuthorship W2810396346A5053500368 @default.
• W2810396346 hasBestOaLocation W28103963461 @default.
• W2810396346 hasConcept C10515644 @default.
• W2810396346 hasConcept C121608353 @default.
• W2810396346 hasConcept C126322002 @default.
• W2810396346 hasConcept C141071460 @default.
• W2810396346 hasConcept C143998085 @default.
• W2810396346 hasConcept C2776283816 @default.
• W2810396346 hasConcept C2777658100 @default.
• W2810396346 hasConcept C2779013556 @default.
• W2810396346 hasConcept C502942594 @default.
• W2810396346 hasConcept C66339696 @default.
• W2810396346 hasConcept C71924100 @default.
• W2810396346 hasConcept C72563966 @default.
• W2810396346 hasConceptScore W2810396346C10515644 @default.
• W2810396346 hasConceptScore W2810396346C121608353 @default.
• W2810396346 hasConceptScore W2810396346C126322002 @default.
• W2810396346 hasConceptScore W2810396346C141071460 @default.
• W2810396346 hasConceptScore W2810396346C143998085 @default.
• W2810396346 hasConceptScore W2810396346C2776283816 @default.
• W2810396346 hasConceptScore W2810396346C2777658100 @default.
• W2810396346 hasConceptScore W2810396346C2779013556 @default.
• W2810396346 hasConceptScore W2810396346C502942594 @default.
• W2810396346 hasConceptScore W2810396346C66339696 @default.
• W2810396346 hasConceptScore W2810396346C71924100 @default.
• W2810396346 hasConceptScore W2810396346C72563966 @default.
• W2810396346 hasIssue "9" @default.
• W2810396346 hasLocation W28103963461 @default.
• W2810396346 hasLocation W28103963462 @default.
• W2810396346 hasLocation W28103963463 @default.
• W2810396346 hasLocation W28103963464 @default.
• W2810396346 hasOpenAccess W2810396346 @default.
• W2810396346 hasPrimaryLocation W28103963461 @default.
• W2810396346 hasRelatedWork W2003837205 @default.
• W2810396346 hasRelatedWork W2113172797 @default.
• W2810396346 hasRelatedWork W2306397891 @default.
• W2810396346 hasRelatedWork W2347402903 @default.
• W2810396346 hasRelatedWork W2351726511 @default.
• W2810396346 hasRelatedWork W2383837988 @default.
• W2810396346 hasRelatedWork W2785160602 @default.
• W2810396346 hasRelatedWork W2992396679 @default.
• W2810396346 hasRelatedWork W3074585435 @default.
• W2810396346 hasRelatedWork W4311732874 @default.
• W2810396346 hasVolume "136" @default.
• W2810396346 isParatext "false" @default.
• W2810396346 isRetracted "false" @default.
• W2810396346 magId "2810396346" @default.
• W2810396346 workType "article" @default.